Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperandrogenism × Sodium Salicylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Inflammation 1 Hyperandrogenism 1 Anovulation 1

Interventions

Metformin 2 salicylsalicylic acid 1 maltodextrin 1 licogliflozin 1 Sugars 1 Sodium Salicylate 1 Inulin 1 Inositol 1 Flutamide 1 Clomiphene 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed

60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡